China Reform Health Management & Services Group Co., Ltd. Class A

As of March 31, 2026, China Reform Health Management & Services Group Co., Ltd. Class A carries a market capitalization of 7.70B, placing it among publicly traded companies globally. Its enterprise value stands at 7.68B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

China Reform Health Management & Services Group Co., Ltd. Class A's next confirmed earnings release is scheduled for October 27, 2026.

As of March 31, 2026, China Reform Health Management & Services Group Co., Ltd. Class A has 979.25M shares outstanding.

These figures are as of March 31, 2026. The price-to-sales ratio is 23.60, and the price-to-book ratio stands at 8.02.

These figures are as of March 31, 2026. The EV/Sales ratio of 23.54 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 7.68B versus a market cap of 7.70B, with the gap driven by net debt and cash on the balance sheet.

As of March 31, 2026, China Reform Health Management & Services Group Co., Ltd. Class A maintains a current ratio of 1.96, meaning it holds 2.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 44.47, indicating elevated leverage, while an interest coverage ratio of -38.21 demonstrates limited ability to service its debt obligations.

Over the twelve months ended March 31, 2026, China Reform Health Management & Services Group Co., Ltd. Class A posted a negative return on equity (ROE) of -34.95, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -21.69, reflecting losses generated across the asset base. The company generates approximately 255,659.04 in revenue per employee across its workforce of 1,275.50, a quick read on workforce productivity versus industry peers. Inventory turnover of 57.37 indicates how many times China Reform Health Management & Services Group Co., Ltd. Class A sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended March 31, 2026, China Reform Health Management & Services Group Co., Ltd. Class A recorded 73,046.39 in income tax expense. The company reported a pretax loss of -413.21M and -413.29M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 23, 2026, China Reform Health Management & Services Group Co., Ltd. Class A's stock has declined approximately 22.36% over the past 52 weeks. The 50-day moving average sits at 7.27, while the 200-day moving average is 7.83.

Over the twelve months ended March 31, 2026, China Reform Health Management & Services Group Co., Ltd. Class A generated 326.09M in revenue and converted that into -413.29M in net income, yielding earnings per share of -0.42. EBITDA reached -411.82M, while operating income came in at -146.18M.

As of March 31, 2026, China Reform Health Management & Services Group Co., Ltd. Class A holds 447.53M in cash and equivalents against 426.57M in total debt, resulting in a net debt position of -3.54M. Total book value stands at 959.17M, with working capital of 585.98M providing operational flexibility.

These figures cover the twelve months ended March 31, 2026.

Over the twelve months ended March 31, 2026, China Reform Health Management & Services Group Co., Ltd. Class A posted a gross margin of 18.56, reflecting its pricing power and cost economics. The operating margin of -44.83 and net profit margin of -126.74 provide insight into operational efficiency.

Over the twelve months ended March 31, 2026, China Reform Health Management & Services Group Co., Ltd. Class A paid dividends of 0.01 per share. The dividend payout ratio of -1.39 is negative because earnings are negative, so the dividend is being paid out of something other than profits, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Total shareholder yield is negative at -0.83, meaning China Reform Health Management & Services Group Co., Ltd. Class A raised more capital through share issuance and new debt than it returned via dividends and buybacks.

China Reform Health Management & Services Group Co., Ltd. Class A's most recent stock split took place on June 10, 2011 with a 5:6 split ratio.

As of March 31, 2026, China Reform Health Management & Services Group Co., Ltd. Class A has an Altman Z-Score of 5.64, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.